Ifp Advisors, Inc Ionis Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,070 shares of IONS stock, worth $39,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,070

Previous 1,070 -0.0%

Holding current value

$39,087

Previous $46,000 8.7%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$43.39 - $51.63 $3,080 - $3,665	-71 Reduced 6.22%	1,070 $54,000
Q3 2023 Oct 12, 2023	SELL	$38.5 - $47.13 $539 - $659	-14 Reduced 1.21%	1,141 $51,000
Q2 2023 Aug 04, 2023	SELL	$34.73 - $43.33 $28,270 - $35,270	-814 Reduced 41.34%	1,155 $47,000
Q1 2023 Apr 18, 2023	SELL	$33.58 - $41.2 $96,341 - $118,202	-2,869 Reduced 59.3%	1,969 $70,000
Q4 2022 Feb 07, 2023	SELL	$37.12 - $46.52 $35,301 - $44,240	-951 Reduced 16.43%	4,838 $233,000
Q2 2022 Sep 06, 2022	BUY	$31.71 - $43.0 $183,569 - $248,927	5,789 New	5,789 $279,000
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $183,569 - $248,927	-5,789 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$29.88 - $37.04 $72,190 - $89,488	2,416 Added 71.63%	5,789 $214,000
Q1 2022 Aug 08, 2022	BUY	$29.88 - $37.04 $20,916 - $25,928	700 Added 26.19%	3,373 $124,000
Q4 2021 Jan 12, 2022	BUY	$25.61 - $35.1 $24,406 - $33,450	953 Added 55.41%	2,673 $93,000
Q3 2021 Oct 06, 2021	BUY	$33.54 - $40.55 $18,145 - $21,937	541 Added 45.89%	1,720 $66,000
Q2 2021 Jul 13, 2021	BUY	$34.54 - $47.25 $30,429 - $41,627	881 Added 295.64%	1,179 $45,000
Q1 2021 Apr 30, 2021	SELL	$42.51 - $63.78 $3,528 - $5,293	-83 Reduced 21.78%	298 $13,000
Q4 2020 Jan 25, 2021	SELL	$45.3 - $60.27 $23,465 - $31,219	-518 Reduced 57.62%	381 $21,000
Q3 2020 Oct 29, 2020	SELL	$47.45 - $62.95 $9,822 - $13,030	-207 Reduced 18.72%	899 $43,000
Q2 2020 Aug 05, 2020	SELL	$46.85 - $61.05 $374 - $488	-8 Reduced 0.72%	1,106 $66,000
Q1 2020 May 12, 2020	SELL	$41.6 - $63.4 $17,264 - $26,311	-415 Reduced 27.14%	1,114 $56,000
Q4 2019 Jan 17, 2020	SELL	$53.85 - $65.27 $91,706 - $111,154	-1,703 Reduced 52.69%	1,529 $92,000
Q3 2019 Nov 07, 2019	BUY	$59.06 - $72.15 $188,519 - $230,302	3,192 Added 7980.0%	3,232 $192,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $47,045 - $72,160	-889 Reduced 95.69%	40 $3,000
Q4 2018 Jan 23, 2019	SELL	$43.37 - $59.54 $3,252 - $4,465	-75 Reduced 7.47%	929 $50,000
Q3 2018 Oct 25, 2018	SELL	$42.88 - $53.7 $62,947 - $78,831	-1,468 Reduced 59.39%	1,004 $0
Q2 2018 Aug 07, 2018	SELL	$40.53 - $50.7 $37,936 - $47,455	-936 Reduced 27.46%	2,472 $0
Q1 2018 Jun 03, 2019	BUY	$44.08 - $55.05 $14,766 - $18,441	335 Added 10.9%	3,408 $171,000
Q1 2018 May 09, 2018	SELL	$44.08 - $55.05 $14,766 - $18,441	-335 Reduced 9.83%	3,073 $0
Q4 2017 Jan 24, 2018	SELL	$50.3 - $64.39 $88,477 - $113,262	-1,759 Reduced 34.04%	3,408 $0
Q3 2017 Oct 30, 2017	SELL	$45.56 - $59.57 $23,372 - $30,559	-513 Reduced 9.03%	5,167 $262,000
Q2 2017 Jun 03, 2019	SELL	N/A	-871 Reduced 13.3%	5,680 $289,000
Q1 2017 Jun 03, 2019	SELL	N/A	-2,483 Reduced 27.49%	6,551 $263,000
Q4 2016 Jun 03, 2019	BUY	N/A	1,928 Added 27.13%	9,034 $432,000
Q2 2016 Jun 03, 2019	BUY	N/A	7,066 Added 17665.0%	7,106 $165,000
Q1 2016 Jun 03, 2019	BUY	N/A	40	40 $3,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account